​

Rezolute (RZLT) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

RZLT Stock Forecast

Rezolute (RZLT) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $9.17, with a high of $14.00 and a low of $6.00. This represents a 137.56% increase from the last price of $3.86.

- $3 $6 $9 $12 $15 High: $14 Avg: $9.17 Low: $6 Last Closed Price: $3.86

RZLT Stock Rating

Rezolute stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 14 Strong Sell Sell Hold Buy Strong Buy

RZLT Price Target Upside V Benchmarks

TypeNameUpside
StockRezolute137.56%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts3416
Avg Price Target$9.33$9.50$8.13
Last Closing Price$3.86$3.86$3.86
Upside/Downside141.71%146.11%110.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26281--11
Sep, 26262--10
Aug, 26262--10
Jul, 26262--10
Jun, 26163--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 06, 2026Daniel BrimsLake Street$12.00$4.25182.35%210.88%
Sep 30, 2026Daniel BrimsLake Street$9.00$4.09120.05%133.16%
Sep 29, 2026Albert LoweCraig-Hallum$7.00$4.1867.46%81.35%
Sep 25, 2026Douglas TsaoH.C. Wainwright$10.00$4.02148.76%159.07%
Jun 03, 2026Yun ZhongWedbush$6.00$4.0050.00%55.44%
Jun 02, 2026BTIG$6.00$4.0050.00%55.44%
Jun 02, 2026Maxim Group$14.00$4.00250.00%262.69%
May 14, 2026Maxim Group$10.00$3.47188.18%159.07%
Jan 08, 2026Wedbush$2.00$2.22-9.91%-48.19%
Dec 12, 2025Jason McCarthyMaxim Group$4.00$1.58153.16%3.63%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2026CitigroupMarket OutperformMarket Outperformhold
Oct 06, 2026Lake StreetBuyBuyhold
Oct 06, 2026CitigroupOutperformOutperformhold
Oct 05, 2026Cantor FitzgeraldNeutralOverweightupgrade
Sep 30, 2026Lake StreetBuyinitialise
Sep 29, 2026Craig-HallumHoldBuyupgrade
Sep 25, 2026H.C. WainwrightBuyBuyhold
Sep 25, 2026HSBCBuyupgrade
Jul 30, 2026H.C. WainwrightBuyBuyhold
Jun 15, 2026GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-1.33$-0.98$-0.75---
Avg Forecast$-1.22$-1.07$-1.16$-0.84$0.78$2.39
High Forecast$-1.17$-0.96$-0.89$-0.22$0.78$2.39
Low Forecast$-1.27$-1.12$-1.62$-1.48$0.78$2.39
Surprise %9.02%-8.41%-35.34%---

Revenue Forecast

$0 $80M $160M $240M $320M $400M Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported------
Avg Forecast-$23.49M$10.80M$43.21M$208.18M$384.92M
High Forecast-$23.49M$10.80M$43.21M$208.18M$384.92M
Low Forecast-$23.49M$10.80M$43.21M$208.18M$384.92M
Surprise %------

Net Income Forecast

$-100M $-50M $0 $50M $100M $150M Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-68.46M$-74.41M$-77.59M---
Avg Forecast$-62.81M$-53.53M$-64.56M$-72.64M$39.94M$122.90M
High Forecast$-60.15M$-49.37M$-45.88M$-11.32M$39.94M$122.90M
Low Forecast$-65.47M$-57.69M$-83.23M$-76.17M$39.94M$122.90M
Surprise %9.00%39.00%20.18%---

RZLT Forecast FAQ

Is Rezolute stock a buy?

Rezolute stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Rezolute is a favorable investment for most analysts.

What is Rezolute's price target?

Rezolute's price target, set by 14 Wall Street analysts, averages $9.17 over the next 12 months. The price target range spans from $6 at the low end to $14 at the high end, suggesting a potential 137.56% change from the previous closing price of $3.86.

How does Rezolute stock forecast compare to its benchmarks?

Rezolute's stock forecast shows a 137.56% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Rezolute over the past three months?

  • October 2026: 18.18% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Rezolute’s EPS forecast?

Rezolute's average annual EPS forecast for its fiscal year ending in June 2027 is $-0.84, marking a 12.00% increase from the reported $-0.75 in 2026. Estimates for the following years are $0.78 in 2028, and $2.39 in 2029.

What is Rezolute’s revenue forecast?

Rezolute's average annual revenue forecast for its fiscal year ending in June 2027 is $43.21M, reflecting a 0% decrease from the reported $0 in 2026. The forecast for 2028 is $208.18M, and $384.92M for 2029.

What is Rezolute’s net income forecast?

Rezolute's net income forecast for the fiscal year ending in June 2027 stands at $-72.642M, representing a -6.37% decrease from the reported $-77.586M in 2026. Projections indicate $39.94M in 2028, and $122.9M in 2029.